News – Page 340 – Endpoints News

BioXcel looks to expand label to at-home use for lead psych drug. Initial data are mixed

3 years ago

Lilly gears up trio of PhIII trials for its oral GLP-1 amid Novo Nordisk, Pfizer competition

3 years ago

Apellis reports PhII ALS fail after stopping open-label extension in April

3 years ago

Boehringer Ingelheim extends 2020 collab with Oxford BioTherapeutics; European biotechs claim positive PhI I/O data

3 years ago

Biopharma's 20 highest-paid CEOs of 2022, each bringing in $20M+ paydays

3 years ago

BenevolentAI lays off around 180 staffers, cuts pipeline programs in reorg

3 years ago

Dutch biotech raises €30M for upscaled manufacturing, pilot study of blood clotting drug

3 years ago

Mirati’s drug sitravatinib flops PhIII in combo with Opdivo for certain lung cancer

3 years ago

Annexon’s GA drug misses on primary goal but win on visual acuity will be focus of planned late-stage trial

3 years ago

Novo Nordisk makes the case it’s more than Wegovy in new corporate ad campaign

3 years ago

District court hands Janssen a win in patent feud with Viatris

3 years ago

Purdue Pharma nabs court approval for $397M sale of consumer health unit

3 years ago

Veeva adds generative AI tool for pharma reps as it rolls out new software platform

3 years ago

UCB enters gene therapy space, inking license agreement for epilepsy and neurodegeneration research

3 years ago

CDMO secures a $98M+ NIH contract for production of pediatric HIV-prevention products

3 years ago

Generally accepted scientific knowledge: FDA explains how it applies to nonclinical data in drug apps

3 years ago

New Biden proposal would expose the actual cost of drugs covered by Medicaid

3 years ago

Eloxx aims to take lead candidate into PhIII for rare disease

3 years ago

Ipsen given an adcomm date for palovarotene; Ambrx Biopharma looks to secure $75M in latest securities offering

3 years ago

FDA delays Sarepta's Duchenne gene therapy decision by a month

3 years ago

The 20(+2) under 40: Your guide to the next generation of biotech leaders

3 years ago

Small SPAC to tiny sale: Apexigen sprints to Pyxis Oncology in $16M exit

3 years ago

Entasis lands first antibiotic approval eight years after spinning out of AstraZeneca

3 years ago

Phathom Pharmaceuticals resubmits NDA for acid blocker, bags $130M+ from offering

3 years ago

First page Previous page 337 338 339340341 342 343 Next page Last page